국회


The Asian Acne Board and Galderma Join Forces to Improve Understanding and Management of Acne

Candidates invited to apply for 10,000 USD research grant award

(Business Wire/Korea Newswire) The Asian Acne Board (AAB) and Galderma are inviting candidates to apply for a research grant of 10,000 USD to contribute to the improvement of best practices in the management of acne. 

The AAB research grant with the unrestricted support of Galderma is focused on advancing the understanding of acne. Research projects that involve clinical or basic research will receive consideration. Dermatology residents, dermatology fellows, and recent dermatology graduates of dermatology residency programs are eligible to apply for this research grant. The completed application and supporting materials must be received by January 15, 2016 and the grant winner will be decided in February, 2016. 

Kamal Abbasi, Regional Vice-President Galderma Asia-Pacific underlines the significance of the research grant by stating that ‘The AAB research grant with the support of Galderma demonstrates our continued and unwavering global commitment to partner with health care physicians in Asia-Pacific. Acne vulgaris is one of the most common cutaneous conditions regardless of race or ethnicity. It is therefore paramount that best practices in the management of acne are supported, communicated and recognized’. 

The AAB research grant is focused on advancing the understanding of acne. Research projects that involve clinical or basic research will receive consideration. 

All of the proposed grant applications are independently reviewed by an international panel of experts in acne, consisting of Professors Sewon Kang (Johns Hopkins, Baltimore, USA & AAB Chair), Chee Leok Goh (National Skin Centre, Singapore & AAB Co-Chair), Nobukazu Hayashi (Toranomon Hospital, Tokyo, Japan), and Dae Hun Suh (Seoul National University, Seoul, Korea). 

About the Asian Acne Board 

The Asian Acne Board (AAB) was formed in 2005 as regional board of international Global Alliance to Improve Outcomes in Acne which is financially supported by Galderma. It involves dermatologists with an interest in acne from Australia, India, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand, Taiwan, China and USA. The AAB established a research grant to contribute to the improvement of best practices in the management of acne in Asia. The Program was formally introduced at the 2011 World Congress of Dermatology in Seoul. 


About Galderma 

Dating back to 1961, Galderma now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails. 

For more information, please visit www.galderma.com 

View source version on businesswire.com: http://www.businesswire.com/news/home/20151201005150/en/
News Source: Galderma
Media Contact
Galderma 
Yvan Deurbroeck 
Global Vice President Communications, Galderma 
Mobile phone: +41 79 254824 
yvan.deurbroeck@galderma.com


경기도, 국내복귀기업에 제조자동화 혁신 비용 최대 5억 원 지원 [경기도=황규진기자] 경기도가 해외에서 국내로 돌아온 국내복귀기업의 안정적인 정착을 위해 제조자동화 구축비로 7년간 최대 5억 원을 지원하는 ‘경기도 국내복귀기업 지원사업’ 참가기업을 5월 17일까지 모집한다. 2020년 시작된 이번 사업의 지원 대상은 산업통상자원부장관으로부터 ‘지원대상 국내복귀기업 선정확인서’를 발급받은 경기도 소재 기업이다. 제조자동화를 위해 선정 기업에 최대 1억 원을 지원하며, 최대 7년간 선정 시 지원가능한 누적 금액은 5억 원이다. 도는 기업 선정 과정에서 신규지원 기업에 가점을 부여하고 복귀 후 7년 경과 또는 해당 사업 지원금 5억 원 이상 수혜기업을 졸업 대상으로 선정한다. 이 같은 지원사업으로 현재까지 20개 기업이 경기도로 복귀했으며, 5개 사가 졸업할 예정이다. 도는 첨단기술산업 등 우수 복귀기업을 발굴하기 위해 대한무역투자진흥공사와 협업해 해외진출기업의 현황과 국내복귀의향을 파악하는 실태조사를 실시할 계획이다. 모집 공고는 이지비즈(www.egbiz.or.kr)를 통해 확인할 수 있으며, 자세한 사항은 경기도경제과학진흥원 투자유치TF(031-259-7012)로 문의하면 된다. 이민우 경기도 투자통상과장은 “이번 제조자